GlassScriptPhysician profile
Maria Pirrera
NPI 1457042525
$1,306.21
in general payments reported to CMS, 2019-2025
13 companies · $558 in 2025
The $558 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $78.39 · 2024: $670 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.99 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $538.15 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $184.86 | 2024 | |
| Boston Scientific Corporation | $152.22 | 2024-2025 | Watchman Flx |
| Medtronic, INC. | $124.68 | 2025 | Protege Rx |
| Glaxosmithkline, LLC. | $70.19 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $50.55 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $44.29 | 2023-2024 | |
| Novo Nordisk INC | $28.69 | 2024 | Ozempic, Rybelsus |
| Dexcom, INC. | $28.64 | 2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $25.18 | 2025 | |
| Nalu Medical, INC. | $23.44 | 2025 | Nalu Neurostimulation System |
| Merck Sharp & Dohme LLC | $18.25 | 2023 | Gardasil 9, Vaxneuvance |
| Amgen INC. | $17.07 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Pirrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.